Literature DB >> 19000937

Delayed diagnosis of a neuroBehçet patient with only brainstem and cerebellar atrophy: literature review.

Ozlem Taskapilioglu1, Meral Seferoglu, Cengiz Akkaya, Bahattin Hakyemez, Canan Yusufoglu, A Nazli Basak, Asli Gundogdu, Ibrahim Bora.   

Abstract

We report a 34-year-old male neuroBehçet's Disease (NBD) patient with atypical magnetic resonance imaging (MRI) findings, whose behavioral problems were followed by progressive neurological symptoms. The patient was hospitalized due to forgetfulness, irritability, behavioral dyscontrol and a choking sensation. T2-weighted MRI showed prominent atrophy of cerebellar hemispheres, the cerebellar peduncle, the midbrain and the pons. He was diagnosed with NBD after an evaluation of his medical history together with neuropsychiatric and laboratory findings. There are few reports of NBD with only brainstem and cerebellar atrophy. We discuss our patient in the context of the four previously reported cases. In NBD without evident mucocutaneo-ocular symptoms, neurologists should always consider the medical and family history. Early diagnosis of NBD helps to initiate appropriate treatment, thereby modulating the course of the disease and preventing complications.

Entities:  

Mesh:

Year:  2008        PMID: 19000937     DOI: 10.1016/j.jns.2008.10.003

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Hypertrophic Olivary Degeneration Secondary to Neuro-Behçet's Disease.

Authors:  W A Martins; L P Schilling; F K Neto; J Becker
Journal:  Clin Neuroradiol       Date:  2015-03-24       Impact factor: 3.649

Review 2.  Behçet's Syndrome and Nervous System Involvement.

Authors:  Uğur Uygunoğlu; Aksel Siva
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

3.  Cortical and cerebellar atrophy, but no lesion in a patient with neuro-Behçet's disease.

Authors:  Asuman Orhan Varoglu; Asude Aksoy; Idris Kocatürk; Ayfer Ertekin; Mustafa Koplay; Faruk Omer Odabas; Seda Ozbek
Journal:  Wien Klin Wochenschr       Date:  2013-04-26       Impact factor: 1.704

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.